TocilizumabV1, Main, Merge, indexHead, AutAff.i

Hematology and Medical Oncology Fellowship, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
États-Unis
Hematology and Medical Oncology Fellowship, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas
Texas

001657

David A. Johnson

États-Unis
Eastern Virginia Medical School, VA, Norfolk
Norfolk

003A69

<g><k>Johnson D</k>
<l><g><k>D Johnson</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000089</i>
<i>000101</i>
<i>000522</i>
<i>000982</i>
<i>000C07</i>
<i>000E32</i>
<i>002005</i>
<i>003935</i>
</l>
<n>8</n>
<t>8</t>
</g>
</l>
<n>1</n>
<t>8</t>
</g>
<g><k>D. B. Johnson</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>001030</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>D. E. Johnson</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000A51</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>D. H. Johnson</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000853</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>D. Johnson</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>001336</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>D.B. Johnson</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000462</i>
<i>000623</i>
<i>000F40</i>
</l>
<n>3</n>
<t>3</t>
</g>
</l>
<n>1</n>
<t>3</t>
</g>
<g><k>D.E. Johnson</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000095</i>
<i>000279</i>
<i>000374</i>
<i>000525</i>
<i>000800</i>
<i>000D83</i>
</l>
<n>6</n>
<t>6</t>
</g>
</l>
<n>1</n>
<t>6</t>
</g>
<g><k>D.S. Johnson</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000A20</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>D.W. Johnson</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000110</i>
<i>000353</i>
</l>
<n>2</n>
<t>2</t>
</g>
</l>
<n>1</n>
<t>2</t>
</g>
<g><k>DA Johnson</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000588</i>
<i>000769</i>
</l>
<n>2</n>
<t>2</t>
</g>
</l>
<n>1</n>
<t>2</t>
</g>
<g><k>DB Johnson</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000033</i>
<i>000208</i>
<i>000260</i>
<i>000265</i>
<i>000749</i>
<i>000A09</i>
<i>000A38</i>
<i>000A80</i>
<i>000A86</i>
<i>000A87</i>
<i>000C07</i>
<i>000C10</i>
<i>000E32</i>
<i>000F83</i>
<i>002018</i>
</l>
<n>15</n>
<t>15</t>
</g>
</l>
<n>1</n>
<t>15</t>
</g>
<g><k>DB. Johnson</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000E72</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>DE Johnson</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000170</i>
<i>000207</i>
<i>000745</i>
<i>000937</i>
<i>000A13</i>
<i>000B67</i>
</l>
<n>6</n>
<t>6</t>
</g>
</l>
<n>1</n>
<t>6</t>
</g>
<g><k>DF Johnson</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000528</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>DH Johnson</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000927</i>
<i>000C10</i>
<i>000F09</i>
<i>001243</i>
</l>
<n>4</n>
<t>4</t>
</g>
</l>
<n>1</n>
<t>4</t>
</g>
<g><k>DL Johnson</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>002005</i>
<i>003935</i>
<i>003C91</i>
<i>004476</i>
</l>
<n>4</n>
<t>4</t>
</g>
</l>
<n>1</n>
<t>4</t>
</g>
<g><k>DM Johnson</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000F09</i>
<i>003C91</i>
</l>
<n>2</n>
<t>2</t>
</g>
</l>
<n>1</n>
<t>2</t>
</g>
<g><k>DS Johnson</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000C33</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>Daniel E. Johnson</k>
<l><g><k><affiliation><nlm:aff id="aff001"></nlm:aff>
</affiliation>
</k>
<l><i>000320</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000095</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>2</n>
<t>2</t>
</g>
<g><k>Daniel Hartman Johnson</k>
<l><g><k><affiliation wicri:level="2"><nlm:affiliation>Hematology and Medical Oncology Fellowship, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Hematology and Medical Oncology Fellowship, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</k>
<l><i>001657</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>David A. Johnson</k>
<l><g><k><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Eastern Virginia Medical School, VA, Norfolk</wicri:regionArea>
<wicri:noRegion>Norfolk</wicri:noRegion>
</affiliation>
</k>
<l><i>003A69</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>21</n>
<t>64</t>
</g>

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021

	Serveur d'exploration Tocilizumab
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Tocilizumab